Method for treating nervous system pathophysiologies using glial growth factors
US6204241A · kind A · utility
0Cited by
1References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 22, 1996 |
| Grant date | Mar 20, 2001 |
| Priority date | — |
| Expiry date | Oct 22, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for treating pathophysiological conditions of the mammalian nervous system. The methods involve administering an effective amount of a polypeptide comprising amino acids 51 to 422 of human GGF2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.